Global Anti–vascular Endothelial Growth Factor Therapy Market Growth (Status and Outlook) 2023-2029

March 2023 | 61 pages | ID: G10B927922D5EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Anti–vascular Endothelial Growth Factor Therapy Industry Forecast” looks at past sales and reviews total world Anti–vascular Endothelial Growth Factor Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti–vascular Endothelial Growth Factor Therapy sales for 2023 through 2029. With Anti–vascular Endothelial Growth Factor Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti–vascular Endothelial Growth Factor Therapy industry.

This Insight Report provides a comprehensive analysis of the global Anti–vascular Endothelial Growth Factor Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti–vascular Endothelial Growth Factor Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti–vascular Endothelial Growth Factor Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti–vascular Endothelial Growth Factor Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti–vascular Endothelial Growth Factor Therapy.

The global Anti–vascular Endothelial Growth Factor Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Anti–vascular Endothelial Growth Factor Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Anti–vascular Endothelial Growth Factor Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Anti–vascular Endothelial Growth Factor Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Anti–vascular Endothelial Growth Factor Therapy players cover Regeneron Pharmaceuticals (Eylea), Genentech and Kanghong Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti–vascular Endothelial Growth Factor Therapy market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Extraction Injection
• Precharge Injection

Segmentation by application

• Macular Degeneration
• Nacular Edema
• Uveitis
• Retinal Vein Occlusion

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Regeneron Pharmaceuticals (Eylea)
• Genentech
• Kanghong Pharmaceutical

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Size 2018-2029
  2.1.2 Anti–vascular Endothelial Growth Factor Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Anti–vascular Endothelial Growth Factor Therapy Segment by Type
  2.2.1 Extraction Injection
  2.2.2 Precharge Injection
2.3 Anti–vascular Endothelial Growth Factor Therapy Market Size by Type
  2.3.1 Anti–vascular Endothelial Growth Factor Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Type (2018-2023)
2.4 Anti–vascular Endothelial Growth Factor Therapy Segment by Application
  2.4.1 Macular Degeneration
  2.4.2 Nacular Edema
  2.4.3 Uveitis
  2.4.4 Retinal Vein Occlusion
2.5 Anti–vascular Endothelial Growth Factor Therapy Market Size by Application
  2.5.1 Anti–vascular Endothelial Growth Factor Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Application (2018-2023)

3 ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY MARKET SIZE BY PLAYER

3.1 Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Players
  3.1.1 Global Anti–vascular Endothelial Growth Factor Therapy Revenue by Players (2018-2023)
  3.1.2 Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Anti–vascular Endothelial Growth Factor Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY BY REGIONS

4.1 Anti–vascular Endothelial Growth Factor Therapy Market Size by Regions (2018-2023)
4.2 Americas Anti–vascular Endothelial Growth Factor Therapy Market Size Growth (2018-2023)
4.3 APAC Anti–vascular Endothelial Growth Factor Therapy Market Size Growth (2018-2023)
4.4 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2018-2023)
5.2 Americas Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2018-2023)
5.3 Americas Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2018-2023)
6.2 APAC Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2018-2023)
6.3 APAC Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Anti–vascular Endothelial Growth Factor Therapy by Country (2018-2023)
7.2 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2018-2023)
7.3 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy by Region (2018-2023)
8.2 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY MARKET FORECAST

10.1 Global Anti–vascular Endothelial Growth Factor Therapy Forecast by Regions (2024-2029)
  10.1.1 Global Anti–vascular Endothelial Growth Factor Therapy Forecast by Regions (2024-2029)
  10.1.2 Americas Anti–vascular Endothelial Growth Factor Therapy Forecast
  10.1.3 APAC Anti–vascular Endothelial Growth Factor Therapy Forecast
  10.1.4 Europe Anti–vascular Endothelial Growth Factor Therapy Forecast
  10.1.5 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Forecast
10.2 Americas Anti–vascular Endothelial Growth Factor Therapy Forecast by Country (2024-2029)
  10.2.1 United States Anti–vascular Endothelial Growth Factor Therapy Market Forecast
  10.2.2 Canada Anti–vascular Endothelial Growth Factor Therapy Market Forecast
  10.2.3 Mexico Anti–vascular Endothelial Growth Factor Therapy Market Forecast
  10.2.4 Brazil Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.3 APAC Anti–vascular Endothelial Growth Factor Therapy Forecast by Region (2024-2029)
  10.3.1 China Anti–vascular Endothelial Growth Factor Therapy Market Forecast
  10.3.2 Japan Anti–vascular Endothelial Growth Factor Therapy Market Forecast
  10.3.3 Korea Anti–vascular Endothelial Growth Factor Therapy Market Forecast
  10.3.4 Southeast Asia Anti–vascular Endothelial Growth Factor Therapy Market Forecast
  10.3.5 India Anti–vascular Endothelial Growth Factor Therapy Market Forecast
  10.3.6 Australia Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.4 Europe Anti–vascular Endothelial Growth Factor Therapy Forecast by Country (2024-2029)
  10.4.1 Germany Anti–vascular Endothelial Growth Factor Therapy Market Forecast
  10.4.2 France Anti–vascular Endothelial Growth Factor Therapy Market Forecast
  10.4.3 UK Anti–vascular Endothelial Growth Factor Therapy Market Forecast
  10.4.4 Italy Anti–vascular Endothelial Growth Factor Therapy Market Forecast
  10.4.5 Russia Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.5 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Forecast by Region (2024-2029)
  10.5.1 Egypt Anti–vascular Endothelial Growth Factor Therapy Market Forecast
  10.5.2 South Africa Anti–vascular Endothelial Growth Factor Therapy Market Forecast
  10.5.3 Israel Anti–vascular Endothelial Growth Factor Therapy Market Forecast
  10.5.4 Turkey Anti–vascular Endothelial Growth Factor Therapy Market Forecast
  10.5.5 GCC Countries Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.6 Global Anti–vascular Endothelial Growth Factor Therapy Forecast by Type (2024-2029)
10.7 Global Anti–vascular Endothelial Growth Factor Therapy Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Regeneron Pharmaceuticals (Eylea)
  11.1.1 Regeneron Pharmaceuticals (Eylea) Company Information
  11.1.2 Regeneron Pharmaceuticals (Eylea) Anti–vascular Endothelial Growth Factor Therapy Product Offered
  11.1.3 Regeneron Pharmaceuticals (Eylea) Anti–vascular Endothelial Growth Factor Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Regeneron Pharmaceuticals (Eylea) Main Business Overview
  11.1.5 Regeneron Pharmaceuticals (Eylea) Latest Developments
11.2 Genentech
  11.2.1 Genentech Company Information
  11.2.2 Genentech Anti–vascular Endothelial Growth Factor Therapy Product Offered
  11.2.3 Genentech Anti–vascular Endothelial Growth Factor Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Genentech Main Business Overview
  11.2.5 Genentech Latest Developments
11.3 Kanghong Pharmaceutical
  11.3.1 Kanghong Pharmaceutical Company Information
  11.3.2 Kanghong Pharmaceutical Anti–vascular Endothelial Growth Factor Therapy Product Offered
  11.3.3 Kanghong Pharmaceutical Anti–vascular Endothelial Growth Factor Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Kanghong Pharmaceutical Main Business Overview
  11.3.5 Kanghong Pharmaceutical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Anti–vascular Endothelial Growth Factor Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Extraction Injection
Table 3. Major Players of Precharge Injection
Table 4. Anti–vascular Endothelial Growth Factor Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Type (2018-2023)
Table 7. Anti–vascular Endothelial Growth Factor Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Application (2018-2023)
Table 10. Global Anti–vascular Endothelial Growth Factor Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Player (2018-2023)
Table 12. Anti–vascular Endothelial Growth Factor Therapy Key Players Head office and Products Offered
Table 13. Anti–vascular Endothelial Growth Factor Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Regions (2018-2023)
Table 18. Global Anti–vascular Endothelial Growth Factor Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Country (2018-2023)
Table 22. Americas Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Type (2018-2023)
Table 24. Americas Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Application (2018-2023)
Table 26. APAC Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Region (2018-2023)
Table 28. APAC Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Type (2018-2023)
Table 30. APAC Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Application (2018-2023)
Table 32. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Country (2018-2023)
Table 34. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Type (2018-2023)
Table 36. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Anti–vascular Endothelial Growth Factor Therapy
Table 45. Key Market Challenges & Risks of Anti–vascular Endothelial Growth Factor Therapy
Table 46. Key Industry Trends of Anti–vascular Endothelial Growth Factor Therapy
Table 47. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Regeneron Pharmaceuticals (Eylea) Details, Company Type, Anti–vascular Endothelial Growth Factor Therapy Area Served and Its Competitors
Table 52. Regeneron Pharmaceuticals (Eylea) Anti–vascular Endothelial Growth Factor Therapy Product Offered
Table 53. Regeneron Pharmaceuticals (Eylea) Anti–vascular Endothelial Growth Factor Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Regeneron Pharmaceuticals (Eylea) Main Business
Table 55. Regeneron Pharmaceuticals (Eylea) Latest Developments
Table 56. Genentech Details, Company Type, Anti–vascular Endothelial Growth Factor Therapy Area Served and Its Competitors
Table 57. Genentech Anti–vascular Endothelial Growth Factor Therapy Product Offered
Table 58. Genentech Main Business
Table 59. Genentech Anti–vascular Endothelial Growth Factor Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Genentech Latest Developments
Table 61. Kanghong Pharmaceutical Details, Company Type, Anti–vascular Endothelial Growth Factor Therapy Area Served and Its Competitors
Table 62. Kanghong Pharmaceutical Anti–vascular Endothelial Growth Factor Therapy Product Offered
Table 63. Kanghong Pharmaceutical Main Business
Table 64. Kanghong Pharmaceutical Anti–vascular Endothelial Growth Factor Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Kanghong Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Anti–vascular Endothelial Growth Factor Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Anti–vascular Endothelial Growth Factor Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Anti–vascular Endothelial Growth Factor Therapy Sales Market Share by Country/Region (2022)
Figure 8. Anti–vascular Endothelial Growth Factor Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Type in 2022
Figure 10. Anti–vascular Endothelial Growth Factor Therapy in Macular Degeneration
Figure 11. Global Anti–vascular Endothelial Growth Factor Therapy Market: Macular Degeneration (2018-2023) & ($ Millions)
Figure 12. Anti–vascular Endothelial Growth Factor Therapy in Nacular Edema
Figure 13. Global Anti–vascular Endothelial Growth Factor Therapy Market: Nacular Edema (2018-2023) & ($ Millions)
Figure 14. Anti–vascular Endothelial Growth Factor Therapy in Uveitis
Figure 15. Global Anti–vascular Endothelial Growth Factor Therapy Market: Uveitis (2018-2023) & ($ Millions)
Figure 16. Anti–vascular Endothelial Growth Factor Therapy in Retinal Vein Occlusion
Figure 17. Global Anti–vascular Endothelial Growth Factor Therapy Market: Retinal Vein Occlusion (2018-2023) & ($ Millions)
Figure 18. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Application in 2022
Figure 19. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Player in 2022
Figure 20. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Anti–vascular Endothelial Growth Factor Therapy Market Size 2018-2023 ($ Millions)
Figure 22. APAC Anti–vascular Endothelial Growth Factor Therapy Market Size 2018-2023 ($ Millions)
Figure 23. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size 2018-2023 ($ Millions)
Figure 25. Americas Anti–vascular Endothelial Growth Factor Therapy Value Market Share by Country in 2022
Figure 26. United States Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Region in 2022
Figure 31. APAC Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Type in 2022
Figure 32. APAC Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Application in 2022
Figure 33. China Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Country in 2022
Figure 40. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Type (2018-2023)
Figure 41. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Application (2018-2023)
Figure 42. Germany Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Anti–vascular Endothelial Growth Factor Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 56. APAC Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 57. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 59. United States Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Canada Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 63. China Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Japan Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 65. Korea Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 67. India Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 68. Australia Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 69. Germany Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 70. France Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 71. UK Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Italy Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Russia Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 74. Spain Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 77. Israel Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Anti–vascular Endothelial Growth Factor Therapy Market Size 2024-2029 ($ Millions)
Figure 80. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share Forecast by Application (2024-2029)